Log in to your IBTimes Account

close
ID
Password

Dr. Reddy's Laboratories inks global distribution deal with Albemarle Corp. for Ibuprofen API



By Staff Reporter
08 July 2008 @ 11:14 pm IST

Hyderabad - India's second largest pharmaceutical company in terms of sales, Dr. Reddy's Laboratories, said, Tuesday, it has signed a global distribution agreement for painkiller and anti-inflammatory drug Ibuprofen API with Albemarle Corporation.


Ibuprofen
India's second largest pharmaceutical company in terms of sales, Dr. Reddy's Laboratories, said, Tuesday, it has signed a global distribution agreement for painkiller and anti-inflammatory drug Ibuprofen API with Albemarle Corporation.
1 of 1

advertisement

According to the deal, the Louisiana-based specialty chemicals company shall supply Ibuprofen API from its Orangeburg plant in South Carolina, US, to Dr. Reddy's for distribution to its global client base.

Financial details of the deal were not disclosed.

"Ibuprofen is used for the management of pain, fever, and inflammation and its market size is estimated at US$2.24 billion globally," the Indian drug maker said in a regulatory filing.

This article is copyrighted by Ibtimes.co.in.

    Click!
  • Rate this article:

Comments

Post Your Comment

You must be an IBTimes member to post a comment. Login | Register



advertisement
More Industries News
Fifty one India-focused funds were among the world's top 100 performing stock funds in the quarter to June as domestic shares leapt by nearly half, ...
India's efforts to build badly needed infrastructure will get a boost from the ruling Congress party's strong mandate for reform, but the count...
The railway minister unveiled a mix of populist measures, including cheap tickets for the poor and no increase in freight or passenger fares, as well as ...

advertisement
 
IBTimes.co.in Web
 
International Business Times© 2009 The Ibtimes Company. All Rights Reserved. Partners